First and co-first authorship: 1. Network Pharmacology-based Analysis and Experimental Exploration of the Anti-diabetic Mechanism of Gegen Qinlian decoction. Frontiers in Pharmacology. 2021,26;12:649606. (IF:5.988 );2.The gut-liver axis modulation of Panax Notoginseng Saponins in Non-alcoholic fatty liver disease. Hepatology International, 2021. 2021；15(2):350-365 (IF:9.029);3.Panax notoginseng saponins modulate the gut microbiota to promote thermogenesis and beige adipocyte reconstruction via leptin-mediated AMPKα/STAT3 signaling in diet-induced obesity. Theranostics 2020; 10(24):11302-11323 (IF:11.60);4. Function of Akkermansia muciniphila in obesity: interactions with lipid metabolism, immune response and gut systems. Front Microbiol. 2020; 11: 219 ( IF:6.064);5.Herbal Medicine in the Treatment of Non-Alcoholic Fatty Liver Diseases-Efficacy, Action Mechanism, and Clinical Application. Frontiers in Pharmacology. 11: 2020 (IF:5.988);6. Panax notoginseng for Inflammation-Related Chronic Diseases: A Review on the Modulations of Multiple Pathways. Am J Chin Med. 2018; 5:1-26 (IF:6.005);7. A monoclonal antibody-based competitive ELISA for the determination of Ruscogenin in Chinese traditional medicines and biological samples. Chin J Nat Med. 2014;12(10):794-9 (IF:3.887);8. Gallic Acid and Diabetes Mellitus: Its Association with Oxidative Stress. 2021;26(23):7115 (IF:4.927)